PREDICT-TBI: Comparison Between the IMPACT's Score and the Clinician's Perception to Predict the Prognosis of Severe and Moderate Traumatic Brain Injury

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT03874546
Collaborator
(none)
83
1
1
29.6
2.8

Study Details

Study Description

Brief Summary

Main objective : To compare the quality of the prognostic assessment, (adverse evolution at 6 months) of severe and moderate traumatic brain injury, performed by the clinician compared to the prognosis described by the IMPACT score.

The Pitié-Salpêtrière hospital is conducting a study evaluating the clinician's prognostic assessment of severe and moderate traumatic brain injury compared to the prognosis described by the IMPACT score. The investigators compare the quality of the clinician's prognostic assessment (adverse evolution at 6 months) of severe and moderate traumatic brain injury to the prognosis described by the IMPACT score.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire
N/A

Detailed Description

Design: Prospective, monocentric, pilot study. The study will be proposed to all patients admitted to the neurosurgical intensive care unit (ICU) at Pitié-Salpêtrière hospital, following a traumatic brain injury (TBI), over a period of 1 year. Around 100 patients will be included.

Day 1 : In the first 24 hours after traumatic brain injury, two clinicians will respond to the research questionnaire assessing their patient's prognosis, including confidence in their prediction and experience in neurological intensive care unit. The known prognostic variables as the IMPACT score in the first 24 hours will be collected.

Day 7 : The same clinicians will respond to the research questionnaire assessing their patient's prognosis, including confidence in their prediction and experience in neurological intensive care unit.

At 6 months : After 6 months, all patients or relatives will undergo a telephone interview (or if applicable during a follow-up visit in standard care) to assess the Glasgow Outcome Scale (GOS). This interview will be blinded to the clinician's prediction and the IMPACT score. For patients identified as GOS 3 or 4, a second GOS telephone interview will be carry out in the following days (<7 days), by a committee of adjudication composed of 2 examiners.

Study Design

Study Type:
Interventional
Actual Enrollment :
83 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Comparison Between the IMPACT's Score and the Clinician's Perception to Predict the Prognosis of Traumatic Brain Injury.
Actual Study Start Date :
Apr 4, 2019
Actual Primary Completion Date :
Feb 22, 2021
Actual Study Completion Date :
Sep 22, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prognostic evaluation

Questionnaire at Day1, Day7 and 6 months.

Other: Questionnaire
Two clinicians will complete a questionnaire that analyses their perception of the patient's prognosis at Day1 and Day7. At 6 months, another clinician will establish the patient prognosis using Glasgow Outcome Scale and Glasgow outcome scale extended. This clinician must not know the patient's IMPACT score and prognosis established at Day 1 and Day 7. His evaluation will be compare to the patient's prognosis established previously (Day1 and Day7).
Other Names:
  • French language questionnaire for clinicians that analyses the clinician's perception of the patient's prognosis
  • Outcome Measures

    Primary Outcome Measures

    1. Compare the quality of the prognostic assessment of severe and moderate traumatic brain injury, performed by the clinician compared to the prognosis described by the IMPACT score. [At 6 month]

      Comparison of the area under the ROC curve of the IMPACT model score for the prediction of the 6-month Glasgow Outcome Scale (GOS) ≤ 3 to the area under the ROC curve of the first day clinician's prediction.

    Secondary Outcome Measures

    1. Differences in prognosis between clinicians based on their experience and specialty. [At 6 months]

      Evaluation of the effect of the clinician's experience (number of years of neuro-ICU exercise) and specialty on the clinician's prognosis ROC curve.

    2. To compare the quality of the prognosis of the clinicians between the 1st day (D1) and the 7th day (D7) post-traumatic. [At 6 months]

      Comparison between the clinician's ROC curves at D1 (between the 6th and the 24th hour) and at D7 of the trauma for the prognosis of the patient.

    3. Evaluate how the clinician's confidence in his prognosis is related to the quality of the prognosis. [At 6 months]

      Evaluation of the effect of the clinician's confidence in his prognosis on the clinician's prognostic ROC curve.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient aged 18 years or older,

    • Hospitalized in the neurosurgical ICU department of the Pitié-Salpêtrière hospital following a head trauma,

    • Presenting a Glasgow Coma Scale (GCS) ≤ 12 in the first 24 hours following the head trauma,

    • Relatives informed of the research and not having objected to the patient's participation in the study.

    Exclusion Criteria:
    • Opposition of the patient,

    • Patient under the protection of justice,

    • Pregnant woman,

    • Modified scale of Rankin> 1 before the traumatic brain injury.

    • Patient unable to speak French.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Réanimation neurochirurgicale, Hôpital Pitié-Salpêtrière Paris France 75013

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Rémy BERNARD, MD, Assistance Publique Hoptiaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT03874546
    Other Study ID Numbers:
    • APHP180477
    • 2018-A03135-50
    First Posted:
    Mar 14, 2019
    Last Update Posted:
    Oct 12, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Assistance Publique - Hôpitaux de Paris
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 12, 2021